NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

NAOV

NanoVibronix Inc

Apr 23 • 04:00PM ET

6.06

Dollar change +0.09
Percentage change 1.51	%

Healthcare • Medical Devices • USA • NASD

Peers: INVA IRIX STXS OFIX PAVM LUNA MLSS ATEC ASMB MVIS

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-13.72	Insider Own	0.09%	Shs Outstand	0.76M	Perf Week	-20.26%
Market Cap	4.60M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.76M	Perf Month	42.59%
Income	-3.71M	PEG	-	EPS next Q	-	Inst Own	4.35%	Short Float	10.86%	Perf Quarter	15.98%
Sales	2.56M	P/S	1.80	EPS this Y	-	Inst Trans	0.09%	Short Ratio	0.03	Perf Half Y	5.01%
Book/sh	1.65	P/B	3.66	EPS next Y	-	ROA	-71.92%	Short Interest	0.08M	Perf Year	-31.14%
Cash/sh	0.99	P/C	6.13	EPS next 5Y	-	ROE	-160.56%	52W Range	1.92 - 16.25	Perf YTD	-6.63%
Dividend Est.	-	P/FCF	-	EPS past 5Y	40.47%	ROI	-536.18%	52W High	-62.71%	Beta	1.54
Dividend TTM	-	Quick Ratio	0.42	Sales past 5Y	69.92%	Gross Margin	58.95%	52W Low	215.63%	ATR (14)	1.27
Dividend Ex-Date	-	Current Ratio	1.22	EPS Y/Y TTM	41.44%	Oper. Margin	-140.03%	RSI (14)	55.83	Volatility	8.34% 22.76%
Employees	31	Debt/Eq	0.19	Sales Y/Y TTM	12.05%	Profit Margin	-144.84%	Recom	1.00	Target Price	10.50
Option/Short	No / Yes	LT Debt/Eq	0.10	EPS Q/Q	-3.18%	Payout	-	Rel Volume	0.02	Prev Close	5.97
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-62.28%	Earnings	-	Avg Volume	2.52M	Price	6.06
SMA20	17.33%	SMA50	37.66%	SMA200	-1.43%	Trades		Volume	57,103	Change	1.51%

Apr-11-25 08:00AM	NanoVibronix Regains Nasdaq Compliance (Business Wire)
Apr-01-25 08:00AM	NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia (Business Wire) -10.56%
Mar-21-25 06:36AM	Why Nanovibronix Inc. (NAOV) Surged On Thursday? (InsiderMonkey)
Mar-14-25 08:00AM	Successful Independent Study of the NanoVibronix UroShield Device Published in the Australian and New Zealand Continence Journal (Business Wire) -16.41%
Mar-12-25 08:00AM	NanoVibronix Announces Reverse Stock Split (Business Wire) -32.15%
09:43AM	Loading…
Feb-14-25 09:43AM	NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp. (Business Wire) -5.58%
Jan-07-25 08:00AM	NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes (Business Wire) -18.30%
05:53AM	Transforming catheter care: NanoVibronix completes successful UroShield US trial (Medical Device Network)
Jan-06-25 11:16AM	NanoVibronix achieves goals of US trial pilot phase with UroShield (Medical Device Network) +16.47%
08:00AM	NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield at the University of Michigan (Business Wire)
Dec-11-24 08:00AM	NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement (Business Wire) -14.29%
Nov-12-24 08:00AM	NanoVibronix Provides Business Update (Business Wire) +5.97%
Oct-09-24 08:30AM	NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany (Business Wire)
Sep-23-24 08:30AM	NanoVibronix Signs Letter of Intent with Potential New Distributor (Business Wire)
Aug-21-24 08:30AM	NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders (Business Wire)
08:30AM	Loading…
May-22-24 08:30AM	NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan (Business Wire)
May-16-24 08:30AM	NanoVibronix Issues Letter to Stockholders (Business Wire)
May-15-24 11:53PM	NAOV Stock Earnings: NanoVibronix Reported Results for Q1 2024 (InvestorPlace)
May-14-24 12:55PM	NanoVibronix Signs Multiyear Distribution Deal With CB Medical for UroShield (MT Newswires)
08:30AM	NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield (Business Wire)
May-03-24 07:31AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
May-01-24 08:00AM	NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs FSS Contract Award (Business Wire) -6.12%
Apr-29-24 09:00AM	Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-24-24 01:00PM	NanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 (ACCESSWIRE)
Apr-10-24 07:52AM	NAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023 (InvestorPlace) -9.15%
Apr-09-24 08:30AM	NanoVibronix Issues Letter to Stockholders (Business Wire)
Mar-28-24 08:30AM	NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield (Business Wire)
Dec-06-23 09:00AM	NanoVibronix Featured in Your Bladder Health Magazine (Business Wire)
Dec-04-23 09:00AM	NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity (Business Wire)
Nov-28-23 09:00AM	NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan (Business Wire) -13.87%
08:30AM	Loading…
Nov-21-23 08:30AM	NanoVibronix Regains Nasdaq Compliance (Business Wire) +9.16%
Nov-14-23 08:30AM	NanoVibronix Issues Letter to Shareholders (Business Wire)
Nov-07-23 08:30AM	NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1 (Business Wire)
Sep-27-23 08:00AM	NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services Drug Tariff (Business Wire)
Sep-06-23 08:30AM	NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting (Business Wire) -8.48%
Aug-30-23 02:29PM	NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules (Business Wire) +67.59%
12:07PM	Why Is NanoVibronix Stock Trading Higher Today? (Benzinga)
08:30AM	NanoVibronix Cites Positive Results from Independent Testing of UroShield (Business Wire)
Aug-29-23 04:05PM	NanoVibronix Responds to CMS Determination for PainShield (Business Wire)
Aug-28-23 08:30AM	NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services Drug Tariff (Business Wire) -14.04%
Aug-23-23 08:45AM	NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus (Business Wire) -5.62%
Jun-14-23 08:30AM	NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guard (Business Wire)
May-18-23 08:30AM	NanoVibronix Issues Letter to Shareholders (Business Wire)
Apr-18-23 08:30AM	NanoVibronix Issues Letter to Shareholders (Business Wire)
Mar-28-23 08:30AM	NanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS) (Business Wire)
Mar-21-23 08:30AM	NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra (Business Wire) +8.29%
Mar-14-23 09:15AM	NanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord Injury (Business Wire)
Mar-03-23 08:30AM	NanoVibronix Regains Nasdaq Compliance (Business Wire)
Feb-22-23 08:30AM	NanoVibronix to Launch Rental Program for PainShield and UroShield (Business Wire) +5.08%
Feb-08-23 12:00PM	NanoVibronix Announces Reverse Stock Split (Business Wire) -15.38%
Jan-18-23 08:30AM	NanoVibronix Provides Update on Expanding Access to PainShield (Business Wire) -7.57%
Dec-15-22 04:05PM	NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today (Business Wire)
Dec-13-22 08:30AM	NanoVibronix Announces Partnership with Peak Medical, Ltd. (Business Wire)
Dec-09-22 06:11AM	Shareholders Will Likely Find NanoVibronix, Inc.'s (NASDAQ:NAOV) CEO Compensation Acceptable (Simply Wall St.)
Dec-01-22 02:06PM	NanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Business Wire)
Nov-29-22 08:07AM	NanoVibronix Announces $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Business Wire) -21.00%
Nov-28-22 03:18PM	NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus (Business Wire) +144.27%
Nov-17-22 06:23AM	NanoVibronix Third Quarter 2022 Earnings: US$0.034 loss per share (vs US$0.26 loss in 3Q 2021) (Simply Wall St.)
Nov-16-22 10:15AM	Interim Results Of NanoVibronix's Uroshield Show Beneficial Effects For Patients (Benzinga)
08:30AM	NanoVibronix Announces Interim Results of Clinical Study for UroShield (Business Wire)
Nov-15-22 08:33AM	NanoVibronix Provides Business Update in Letter to Shareholders (Business Wire)
Oct-19-22 08:30AM	NanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement (Business Wire)
Sep-23-22 08:30AM	NanoVibronix UroShield Approved for Sale through NHS Internal Supply Chain Contract (Business Wire) +25.17%
Sep-14-22 04:05PM	NanoVibronix Sets Date for Annual Shareholder Meeting (Business Wire)
09:25AM	NanoVibronix Announces Distribution of Series F Preferred Stock to Holders of its Common Stock (Business Wire)
Sep-02-22 04:30PM	NanoVibronix Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing (Business Wire) -14.88%
Aug-18-22 11:30AM	NanoVibronix Provides Business Update in Letter to Shareholders (Business Wire)
Jul-25-22 08:30AM	Will NanoVibronix (NASDAQ:NAOV) Spend Its Cash Wisely? (Simply Wall St.) -5.15%
Jul-12-22 08:30AM	NanoVibronix Announces Webinar Series to Promote UroShield (Business Wire)
Jun-29-22 08:30AM	NanoVibronix Strengthening Supply Chain Increasing Efficiency and Scalability (Business Wire)
May-17-22 08:30AM	NanoVibronix Reports First Quarter 2022 Financial Results (Business Wire) +5.16%
May-04-22 08:30AM	NanoVibronix Announces FDA 510(k) Submission for PainShield® MD PLUS (Business Wire) +5.39%
Apr-25-22 08:30AM	NanoVibronix Adds Additional Product to Federal Supply Schedule (Business Wire) +7.40%
Apr-05-22 08:30AM	NanoVibronix Advances Efforts to Achieve NHS Approval (Business Wire) -7.63%
Mar-30-22 11:16AM	Health Canada Approves NanoVibronix's PainGuard, UroGuard As Licensed Devices (Benzinga) +22.64%
08:30AM	NanoVibronix Announces PainGuard and UroGuard Approved by Health Canada as Licensed Medical Devices (Business Wire)
Feb-14-22 01:45PM	Is NanoVibronix (NASDAQ:NAOV) In A Good Position To Deliver On Growth Plans? (Simply Wall St.) -5.86%
Feb-07-22 08:30AM	NanoVibronix Added an Additional National Payer Network in Workers Compensation Market (Business Wire)
Jan-31-22 04:15PM	AM Best Upgrades Ratings of CNO Financial Group to A (Excellent) (PR Newswire)
Jan-24-22 08:30AM	NanoVibronix Extends Reach of UroShield and PainShield through MTSGs International Network (Business Wire)
Jan-19-22 08:30AM	NanoVibronix Files Three U.S. Patent Applications Further Leveraging Its Innovative Surface Acoustic Wave Technology (Business Wire)
Jan-13-22 08:30AM	NanoVibronix Expands Board of Directors with Appointment of Two New Independent Directors (Business Wire)
Jan-07-22 01:02PM	NanoVibronix to Present at the H.C. Wainwright BioConnect Virtual Conference (Business Wire)
Jan-06-22 08:30AM	NanoVibronix Further Expands VA Distribution Network to Include SDVOSB Delta Medical, LLC (Business Wire)
Jan-05-22 08:30AM	NanoVibronix Selects Key Distributor to Exclusively Distribute PainShield for Veterans Administration Facilities (Business Wire) -7.27%
Dec-21-21 03:15PM	NanoVibronix, Medina Ink Distribution Pact For Ultrasound Devices In Europe (Benzinga)
10:30AM	NanoVibronix Adjourns Special Meeting of Stockholders (GlobeNewswire)
08:00AM	NanoVibronix Announces Agreement With Medina Healthcare Limited for Distribution of UroShield® and PainShield® in European Market Expansion (Business Wire)
Dec-15-21 09:01AM	11 Best One Dollar Stocks to Buy Today (Insider Monkey) +6.93%
Dec-08-21 11:10AM	CNO Financial Group Selects 2021 Holiday and New Year's Card Winner (PR Newswire)
08:30AM	NANOVIBRONIX TO SHOWCASE PAINSHIELD PRODUCTS AT 75TH ANNUAL WORKERS COMPENSATION EDUCATIONAL CONFERENCE DECEMBER 12-15 (GlobeNewswire)
Dec-07-21 09:00AM	CNO Financial Group Names Richard Shaffer Senior Vice President (PR Newswire)
08:30AM	NanoVibronix Announces Encouraging Interim Results in Real World Patient Study of UroShield (GlobeNewswire)
Dec-02-21 05:30AM	NanoVibronix Announces Early Success in the Marketing of Painshield to Veterans Administration Healthcare Providers (GlobeNewswire)
Nov-16-21 08:30AM	NanoVibronix Reports Third Quarter 2021 Financial Results (Business Wire) -9.72%
Oct-28-21 09:28AM	NanoVibronix CEO Brian Murphy Provides Business Update in Letter to Shareholders (GlobeNewswire)
Oct-11-21 10:40AM	NanoVibronix Shares Gain As PainShield Shows Effectiveness In Treating Soft Tissue Pain (Benzinga) +17.65%
09:06AM	NANOVIBRONIX ANNOUNCES POSITIVE RESULTS FROM INDEPENENT, DOUBLE-BLIND TRIAL OF PAINSHIELD (GlobeNewswire)
Sep-29-21 10:14AM	NANOVIBRONIX ENTERS WORKERS COMPENSATION MARKET THROUGH AGREEMENT WITH ORCHID MEDICAL (GlobeNewswire) +7.03%
Sep-14-21 12:12PM	NanoVibronix Launches CBD-Based Product For Pain Management (Benzinga) -9.46%

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NAOV

NanoVibronix Inc

Upgrade your FINVIZ experience